Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Impact of trial attrition rates on treatment effect estimates in chronic inflammatory diseases: A meta‐epidemiological study
Silja Hvid Overgaard, Caroline Moos, John P A Ioannidis, George Luta, Johannes Berg, Sabrina Mai Nielsen, Vibeke Andersen, Robin Christensen (2024). Impact of trial attrition rates on treatment effect estimates in chronic inflammatory diseases: A meta‐epidemiological study. , 15(4), DOI: https://doi.org/10.1002/jrsm.1708.
Article145 days agoInfluence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological study
Johannes Iuel Berg, Sabrina Mai Nielsen, Esben Malm, John P A Ioannidis, Daniel E. Furst, Josef S Smolen, Peter C. Taylor, L. E. Kristensen, Simon Tarp, Torkell Ellingsen, Robin Christensen (2024). Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological study. , 84(3), DOI: https://doi.org/10.1136/ard-2024-226129.
Article145 days agoStakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group
Dorthe B. Berthelsen, Lee S. Simon, John P A Ioannidis, Marieke Voshaar, P. Scott Richards, Niti Goel, Vibeke Strand, Sabrina Mai Nielsen, Beverly Shea, Peter Tugwell, Susan J. Bartlett, Glen Hazlewood, Lyn March, Jasvinder A. Singh, María E. Suarez‐Almazor, Maarten Boers, Randall M. Stevens, Daniel E. Furst, Thasia Woodworth, Amye Leong, Peter Brooks, Caroline Flurey, Robin Christensen (2023). Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group. , 63, DOI: https://doi.org/10.1016/j.semarthrit.2023.152288.
Article145 days agoStakeholder Endorsement Advancing the Implementation of a Patient-Reported Domain for Harms in Rheumatology Clinical Trials: Outcome of the Omeract Safety Working Group
Dorthe B. Berthelsen, Lee S. Simon, John P A Ioannidis, Marieke Voshaar, P. Scott Richards, Niti Goel, Vibeke Strand, Sabrina Mai Nielsen, Beverly Shea, Peter Tugwell, Susan J. Bartlett, Glen Hazlewood, Lyn March, Jasvinder A. Singh, María E. Suarez‐Almazor, Maarten Boers, Randall M. Stevens, Daniel E. Furst, Thasia Woodworth, Amye Leong, Peter Brooks, Caroline Flurey, Robin Christiansen, OMERACT Safety Working Group (2023). Stakeholder Endorsement Advancing the Implementation of a Patient-Reported Domain for Harms in Rheumatology Clinical Trials: Outcome of the Omeract Safety Working Group. , DOI: https://doi.org/10.2139/ssrn.4557532.
Preprint145 days agoRisk of harm in synthetic and biological intervention trials in patients with inflammatory arthritis: protocol for a metaepidemiological study focusing on contextual factors
Esben Malm, Sabrina Mai Nielsen, Johannes Berg, John P A Ioannidis, Daniel E. Furst, Josef S Smolen, Peter C. Taylor, Lars Erik Kristensen, Simon Tarp, Torkell Ellingsen, Robin Christensen (2021). Risk of harm in synthetic and biological intervention trials in patients with inflammatory arthritis: protocol for a metaepidemiological study focusing on contextual factors. , 11(9), DOI: https://doi.org/10.1136/bmjopen-2021-049850.
Article145 days ago